A Study of LY3050258 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy Participants
Interventions
DRUG

LY3050258

DRUG

Placebo

Trial Locations (1)

10013

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., New York

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01929707 - A Study of LY3050258 in Healthy Participants | Biotech Hunter | Biotech Hunter